Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 40, Issue 6, Pages 1385-1403
Publisher
Oxford University Press (OUP)
Online
2014-03-18
DOI
10.1093/schbul/sbu030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
- (2013) L. Fredrik Jarskog et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight
- (2013) Chun-Hsin Chen et al. JOURNAL OF CLINICAL PSYCHIATRY
- The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
- (2013) Ahmad Ghanizadeh et al. SCHIZOPHRENIA RESEARCH
- No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia
- (2013) Jie Li et al. SCHIZOPHRENIA RESEARCH
- Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia
- (2012) X. Fan et al. ACTA PSYCHIATRICA SCANDINAVICA
- Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
- (2012) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study
- (2012) Man Wang et al. SCHIZOPHRENIA RESEARCH
- Pro12Ala polymorphism of the PPAR-γ2 gene, metabolic syndrome and response to metformin in clozapine-treated patients
- (2012) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial
- (2010) Preeta Kaur Narula et al. SCHIZOPHRENIA RESEARCH
- Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin
- (2010) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study
- (2010) Lauren C. Bresee et al. SCHIZOPHRENIA RESEARCH
- A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia
- (2009) D. C. Henderson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comorbid Somatic Illnesses in Patients With Severe Mental Disorders
- (2009) W. Wolfgang Fleishhacker et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
- (2009) David C. Henderson et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial
- (2009) T. Baptista et al. PHARMACOPSYCHIATRY
- Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
- (2009) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study
- (2008) Trino Baptista et al. PSYCHIATRY RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started